FemPulse Granted European Patent – Adding to US, China, and Australia
FemPulse Corporation today announced the issuance of a European patent covering its vaginally-inserted nerve stimulation technology.
Courtney Lane, PhD to Manage FemPulse Pivotal Clinical Trial
FemPulse Corporation today announced that Courtney Lane, PhD, will be managing the Company’s pivotal clinical trial.
Robert Taub to Represent FemPulse Series B Investors
FemPulse Corporation today announced that Robert Taub will join the Company’s board of directors as the representative of the Series B investors.
Could a doughnut-shaped nerve zapper cure overactive bladders in women?
FemPulse featured in Daily Mail article: Could a doughnut-shaped nerve zapper cure overactive bladders in women?
